Thermo Fisher Scientific TMO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.66B+9.6% | $1.97B+8.0% | $1.62B-0.5% | $1.62B+4.2% | $1.51B+13.5% | ||
| $83M+10.7% | $84M+6.3% | $70M+2.9% | $81M-3.6% | $75M+7.1% | ||
| -$258M+7.5% | —— | -$127M+68.3% | -$322M+62.6% | -$279M-210% | ||
| $1.19B+64.9% | $3.46B+5.1% | $2.24B+3.4% | $1.4B-28.6% | $723M-42.2% | ||
| $376M+3.9% | $465M-3.1% | $404M+48.5% | $294M-2.3% | $362M+4.3% | ||
| $8.87B— | —— | —— | —— | $0— | ||
| $14M-94.7% | $32M-97.6% | $40M-86.1% | $47M+135% | $264M-85.0% | ||
| -$8.96B-1,600% | —— | -$4.12B-15.2% | -$288M-13.8% | -$527M+74.0% | ||
| $162M+8.7% | $162M+8.7% | $163M+8.7% | $162M+8.7% | $149M+10.4% | ||
| $3B+50.0% | $37M-96.3% | $963M— | $0— | $2B-33.3% | ||
| $5.24B+84.4% | $4.92B— | —— | —— | $2.84B+136% | ||
| $1.41B+68.5% | $787M-68.5% | $0-100% | $787M— | $838M— | ||
| $1.09B+1,172% | $3.53B+196% | -$632M+46.9% | -$991M-762% | -$102M+94.4% | ||
| $78M+111% | —— | —— | $311M+2,173% | $37M+68.2% | ||
| -$6.6B-5,099% | $7.87B+1,349% | -$2.59B-6.8% | $431M— | $132M+105% | ||
| $430M+0.2% | $436M-0.5% | $435M-3.1% | $430M-16.3% | $429M-22.1% | ||
| $1.11B-22.0% | —— | $104M— | $726M+236% | $1.43B+81.1% | ||
| -$88M+34.8% | -$140M+44.9% | -$117M-20.6% | -$63M+39.4% | -$135M-155% | ||
| —— | $93.75M+131% | $93.75M+131% | $93.75M+131% | $93.75M+131% | ||
| $55M+5,400% | -$1M+66.7% | -$14M-600% | -$7M-40.0% | $1M+114% | ||
| $250M+12,400% | $1.31B-25.6% | —— | —— | $2M— | ||
| $9M-25.0% | $27M+58.8% | $4M-80.0% | $1M-93.8% | $12M+200% | ||
| $96M+10.3% | $50M+2.0% | $84M-8.7% | $47M0.0% | $87M+35.9% | ||
| $389M— | —— | —— | —— | $0— | ||
| $39M-13.3% | $91M— | -$4M-106% | —— | $45M-59.1% | ||
| $816M+126% | $2.99B+6.5% | $1.84B-3.1% | $1.11B-33.4% | $361M-60.1% | ||
| $816M+126% | $2.99B+6.5% | $1.84B-3.1% | $1.11B-33.4% | $361M-60.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Thermo Fisher Scientific generate?
- Thermo Fisher Scientific (TMO) generated $8.3B in operating cash flow over the trailing twelve months.
- What is Thermo Fisher Scientific's free cash flow?
- After $1.5B of capital expenditures, Thermo Fisher Scientific's free cash flow was $6.7B over the trailing twelve months, up 0.4% year over year.
- Where does Thermo Fisher Scientific's cash flow data come from?
- Every line is extracted from Thermo Fisher Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
